ILMN vs KALV · rev $4.34B vs rev $13.7M
Illumina Inc (ILMN) versus Kalvista Pharmaceuticals Inc (KALV) — a side-by-side from cached financials, not a winner call.
Illumina Inc (ILMN) is a diagnostics & research company listed on US. It is led by Jacob Thaysen Ph.D..
Kalvista Pharmaceuticals Inc (KALV) is a biotechnology company listed on NASDAQ.
Latest reported ILMN revenue for 2025-12-28 was $4.34B. Net income was $850.0M. ILMN currently screens at market cap $15.84B.
Latest reported KALV revenue for 2025-09-30 was $13.7M. Net income was -$158.9M. KALV currently screens at market cap $1.44B.
ILMN currently screens at market cap $15.84B. KALV currently screens at market cap $1.44B.
Not investment advice. Open the ILMN and KALV stock pages for the full models.
Not investment advice.